Atriance, Infusionslösung

7680578990021 CH-57899 Infusionslösung

Associated product:

ATRIANCE sol perf 250 mg/50ml flac 50 ml
Atriance, Infusionslösung
Atriance, Infusionslösung
Atriance, Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/07/2022
Summary of Product Characteristics
Français
29/07/2022
Summary of Product Characteristics
Italien
29/07/2022

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
89.075 MG Substance HBESI

Reimbursement information

Public price
CHF 336.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2021

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
57899
Drug name
Atriance, Infusionslösung
Galenic form
LSPA
ATC Code
L01BB07
Authorization status
Z
Dispensing category
A
First authorization
08/08/2007
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Behandlung von akuter lymphoblastischer T-Zell-Leukämie und lymphoblastischem T-Zell-Lymphom

Package details

Description (FR)
ATRIANCE sol perf 250 mg/50ml flac 50 ml
Description (DE)
ATRIANCE Inf Lös 250 mg/50ml Durchstf 50 ml
Market launch
08/08/2007
Narcotic (BTM)
No

Other package sizes (1)

ATRIANCE sol perf 250 mg/50ml 6 vial 50 ml
None None
GTIN: 7680578990014
Not in V1